Meanwhile, a recent study indicated that high Tspan7 expression may be used to predict poor prognosis and high risk of metastasis in patients with pancreatic cancer, particularly those with Tumor-Node-Metastasis stages I and II (Luo et al., 2021). This evidence concerns the gene TSPAN7 and neoplasm.